No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses

Dimiter S. Dimitrov; Shibo Jiang; Tianlei Ying; Chien Te K. Tseng; Linqi Zhang; Kwok Yung Yuen

doi:10.1073/pnas.1513441112

No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses

Dimiter S. Dimitrov
, Shibo Jiang
, Tianlei Ying
, Chien Te K. Tseng
, Linqi Zhang
, Kwok Yung Yuen

Microbiology And Immunology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	E5115
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	112
Issue number	37
DOIs	https://doi.org/10.1073/pnas.1513441112
State	Published - Sep 15 2015

ASJC Scopus subject areas

General

Access to Document

10.1073/pnas.1513441112

Cite this

No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses. / Dimitrov, Dimiter S.; Jiang, Shibo; Ying, Tianlei et al.
In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, No. 37, 15.09.2015, p. E5115.

Research output: Contribution to journal › Letter › peer-review

@article{d53e77ad751a487096fea3c90b3b8309,

title = "No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses",

author = "Dimitrov, \{Dimiter S.\} and Shibo Jiang and Tianlei Ying and Tseng, \{Chien Te K.\} and Linqi Zhang and Yuen, \{Kwok Yung\}",

year = "2015",

month = sep,

day = "15",

doi = "10.1073/pnas.1513441112",

language = "English (US)",

volume = "112",

pages = "E5115",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

number = "37",

}

TY - JOUR

T1 - No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses

AU - Dimitrov, Dimiter S.

AU - Jiang, Shibo

AU - Ying, Tianlei

AU - Tseng, Chien Te K.

AU - Zhang, Linqi

AU - Yuen, Kwok Yung

PY - 2015/9/15

Y1 - 2015/9/15

UR - https://www.scopus.com/pages/publications/84941711110

UR - https://www.scopus.com/pages/publications/84941711110#tab=citedBy

U2 - 10.1073/pnas.1513441112

DO - 10.1073/pnas.1513441112

M3 - Letter

C2 - 26318165

AN - SCOPUS:84941711110

SN - 0027-8424

VL - 112

SP - E5115

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

IS - 37

ER -

No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this